Cargando…
THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer
BACKGROUND: Long-term use of adjuvant endocrine therapy (AET) among women with early-stage, hormone receptor-positive breast cancer significantly reduces the risk of hospitalizations, cancer recurrence, and mortality. AET is associated with adverse symptoms that often result in poor adherence. A web...
Autores principales: | Paladino, Andrew J., Anderson, Janeane N., Krukowski, Rebecca A., Waters, Teresa, Kocak, Mehmet, Graff, Carolyn, Blue, Ryan, Jones, Tameka N., Buzaglo, Joanne, Vidal, Gregory, Schwartzberg, Lee, Graetz, Ilana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924011/ https://www.ncbi.nlm.nih.gov/pubmed/31856812 http://dx.doi.org/10.1186/s12913-019-4588-x |
Ejemplares similares
-
THRIVE intervention development: using participatory action research principles to guide a mHealth app-based intervention to improve oncology care
por: Anderson, Janeane N., et al.
Publicado: (2021) -
An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancer
por: Paladino, Andrew J., et al.
Publicado: (2022) -
Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer
por: Hu, Xin, et al.
Publicado: (2022) -
An unmet need: tailoring extended adjuvant endocrine therapy
por: Bianchini, G, et al.
Publicado: (2013) -
Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer Before Starting Chemotherapy
por: Hu, Xin, et al.
Publicado: (2021)